Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner

Abstract

p73, a member of the p53 family, can induce apoptosis in cancer cells. Since p53-mediated apoptosis can be augmented by various cancer chemotherapeutic agents, it has been hypothesized that the status of the endogenous p53 gene in cancer cells is a key determinant in the outcome of cancer therapy. To determine whether p73 can sensitize cancer cells to apoptosis by DNA damage agents, several MCF7 adenocarcinoma cell lines that inducibly express p73 or p53 under a tetracycline-regulated promoter were generated. We found that at relevant physiological levels, p73, but not p53, is capable of sensitizing MCF7 cells to apoptosis induced by chemotherapeutic agents. In addition, we found that p73 can cooperate with the DNA damaging agent camptothecin to activate the initiator caspase 2. Furthermore, we found that p73 can cooperate with DNA damaging agents or p53 to induce some p53 target genes and activate their promoters. In contrast, in MCF7E6 cells that ectopically express the human papillomavirus E6 oncogene and are functionally p53-null, the ability of p73 to sensitize cells to apoptosis is abrogated. Taken together, these results suggest that a functional interaction between p53 and p73 in MCF7 cells leads to enhanced induction of apoptosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Agami R, Blandino G, Oren M, Shaul Y . 1999 Nature 399: 809–813

  • Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR . 1998 J. Biol. Chem. 273: 1–4

  • Chen X . 1999 Mol. Med. Today 5: 387–392

  • Chen X, Bargonetti J, Prives C . 1995 Cancer Res. 55: 4257–4263

  • Chen X, Ko LJ, Jayaraman L, Prives C . 1996 Genes Dev. 10: 2438–2451

  • Chresta CM, Masters JR, Hickman JA . 1996 Cancer Res. 56: 1834–1841

  • De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M, Melino G . 1998 J. Exp. Med. 188: 1763–1768

  • Di Como CJ, Gaiddon C, Prives C . 1999 Mol. Cell. Biol. 19: 1438–1449

  • Fan S, Smith ML, Rivet II. DJ, Duba D, Zhan Q, Kohn KW, Fornace Jr. AJ, O'Connor PM . 1995 Cancer Res. 55: 1649–1654

  • Friedlander P, Haupt Y, Prives C, Oren M . 1996 Mol. Cell. Biol. 16: 4961–4971

  • Gallardo D, Drazan KE, McBride WH . 1996 Cancer Res. 56: 4891–4893

  • Giaccia AJ, Kastan MB . 1998 Genes Dev. 12: 2973–2983

  • Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin Jr WG, Levrero M, Wang JY . 1999 Nature 399: 806–809

  • Gupta M, Fan S, Zhan Q, Kohn KW, O'Connor PM, Pommier Y . 1997 Clin. Cancer Res. 3: 1653–1660

  • Hermeking H, Lengauer C, Polyak K, He T-C, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B . 1997 Mol. Cell. 1: 3–11

  • Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D, Nakagawara A . 1999 Oncogene 18: 1061–1066

  • Jost CA, Marin MC, Kaelin Jr WG . 1997 Nature 389: 191–194

  • Kaelin Jr WG . 1999a J. Natl. Cancer Inst. 91: 594–598

  • Kaelin Jr WG . 1999b Oncogene 18: 7701–7705

  • Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D . 1997 Cell 90: 809–819

  • Ko LJ, Prives C . 1996 Genes. Dev. 10: 1054–1072

  • Laurenzi VD, Catani M, Costanzo A, Terrinoni A, Corazzari M, Levrero M, Knight R, Melino G . 1999 Cell. Death Differ. 6: 389–390

  • Lee JM, Bernstein A . 1993 Proc. Natl. Acad. Sci. USA 90: 5742–5746

  • Levine AJ . 1997 Cell 88: 323–331

  • Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T . 1994 Science 266: 807–810

  • Lowe SW, Ruley HE, Jacks T, Housman DE . 1993 Cell 74: 957–967

  • Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T, Kaelin Jr WG . 2000 Nat. Genet. 25: 47–54

  • Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D, Kaelin Jr WG . 1998 Mol. Cell. Biol. 18: 6316–6324

  • Morgenstern JP, Land H . 1990 Nucleic Acids Res. 18: 3587–3596

  • Moustakas A, Kardassis D . 1998 Proc. Natl. Acad. Sci. USA 95: 6733–6738

  • Mukhopadhyay T, Roth JA . 1997 Oncogene 14: 379–384

  • Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R . 1989 J. Virol. 63: 4417–4421

  • Nagata S . 2000 Exp. Cell. Res. 256: 12–18

  • O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace Jr AJ, Kohn KW . 1997 Cancer Res. 57: 4285–4300

  • Prives C, Hall PA . 1999 J. Pathol. 187: 112–126

  • Resnick-Silverman L, St Clair S, Maurer M, Zhao K, Manfredi JJ . 1998 Genes Dev. 12: 2102–2107

  • Wang Y, Blandino G, Oren M, Givol D . 1998 Oncogene 17: 1923–1930

  • Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace Jr AJ, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE, Paull KD . 1997 Science 275: 343–349

  • Xiao H, Hasegawa T, Isobe K . 1999 J. Cell. Biochem. 73: 291–302

  • Yang A, McKeon F . 2000 Nature Rev. Mol. Cell. Biol. 1: 199–207

  • Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B . 1999 Proc. Natl. Acad. Sci. USA 96: 14517–14522

  • Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R, Kufe D . 1999 Nature 399: 814–817

  • Zaika AI, Kovalev S, Marchenko ND, Moll UM . 1999 Cancer Res. 59: 3257–3263

  • Zhu J, Jiang J, Zhou W, Chen X . 1998a Cancer Res. 58: 5061–5065

  • Zhu J, Zhang S, Jiang J, Chen X . 2000 J. Biol. Chem. 275: 39927–39934

  • Zhu J, Zhou W, Jiang J, Chen X . 1998b J. Biol. Chem. 273: 13030–13036

Download references

Acknowledgements

We are grateful to Rhea Markowitz for critical reading of this manuscript. We would like to thank William Kaelin, Jr for providing simian p73 cDNAs. This work is supported in part by Grant RO1 CA81237 from the National Institutes of Health and Grant DAMD 17-97-1-7019 from the DOD Breast Cancer Research Program.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xinbin Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, J., Nozell, S., Wang, J. et al. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner. Oncogene 20, 4050–4057 (2001). https://doi.org/10.1038/sj.onc.1204516

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204516

Keywords

This article is cited by

Search

Quick links